BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27793909)

  • 1. Attenuation of Colchicine Toxicity in Drug-resistant Cancer Cells by Co-treatment with Anti-malarial Drugs.
    Choi AR; Kim JH; Cheon JH; Kim HS; Yoon S
    Anticancer Res; 2016 Nov; 36(11):5859-5866. PubMed ID: 27793909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-malarial Drugs Primaquine and Chloroquine Have Different Sensitization Effects with Anti-mitotic Drugs in Resistant Cancer Cells.
    Choi AR; Kim JH; Woo YH; Kim HS; Yoon S
    Anticancer Res; 2016 Apr; 36(4):1641-8. PubMed ID: 27069141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition.
    Kim JH; Choi AR; Kim YK; Yoon S
    Biochem Biophys Res Commun; 2013 Nov; 441(3):655-60. PubMed ID: 24284282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly Halaven-resistant KBV20C Cancer Cells Can Be Sensitized by Co-treatment with Fluphenazine.
    Cheon JH; Lee BM; Kim HS; Yoon S
    Anticancer Res; 2016 Nov; 36(11):5867-5874. PubMed ID: 27793910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-gp Inhibition by XL019, a JAK2 Inhibitor, Increases Apoptosis of Vincristine-treated Resistant KBV20C Cells with Increased p21 and pH2AX Expression.
    Cheon JH; Kim JY; Lee BM; Kim HS; Yoon S
    Anticancer Res; 2017 Dec; 37(12):6761-6769. PubMed ID: 29187454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-gp Inhibition by the Anti-psychotic Drug Pimozide Increases Apoptosis, as well as Expression of pRb and pH2AX in Highly Drug-resistant KBV20C Cells.
    Kim JY; Park Y; Lee BM; Kim HS; Yoon S
    Anticancer Res; 2018 Oct; 38(10):5685-5692. PubMed ID: 30275188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-treatment with Celecoxib or NS398 Strongly Sensitizes Resistant Cancer Cells to Antimitotic Drugs Independent of P-gp Inhibition.
    Lim JS; Park Y; Lee BM; Kim HS; Yoon S
    Anticancer Res; 2016 Oct; 36(10):5063-5070. PubMed ID: 27798865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging-related Repositioned Drugs, Donepezil and Sildenafil Citrate, Increase Apoptosis of Anti-mitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms.
    Kim JY; Son JY; Lee BM; Kim HS; Yoon S
    Anticancer Res; 2018 Sep; 38(9):5149-5157. PubMed ID: 30194162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine.
    Cheon JH; Kim KS; Yadav DK; Kim M; Kim HS; Yoon S
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1176-1182. PubMed ID: 28669723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK2 Inhibitor, Fedratinib, Inhibits P-gp Activity and Co-Treatment Induces Cytotoxicity in Antimitotic Drug-Treated P-gp Overexpressing Resistant KBV20C Cancer Cells.
    Oh Y; Lee JS; Lee JS; Park JH; Kim HS; Yoon S
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly Eribulin-resistant KBV20C Oral Cancer Cells Can Be Sensitized by Co-treatment with the Third-generation P-Glycoprotein Inhibitor, Elacridar, at a Low Dose.
    Park Y; Son JY; Lee BM; Kim HS; Yoon S
    Anticancer Res; 2017 Aug; 37(8):4139-4146. PubMed ID: 28739698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition.
    Kim JY; Park YJ; Lee BM; Yoon S
    Anticancer Res; 2019 Jul; 39(7):3757-3765. PubMed ID: 31262902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Doses of the Anti-psychotic Drug Aripiprazole Have Strong P-gp-inhibitory Activity and Sensitize Anti-mitotic Drug-resistant Cancer Cells.
    Kim JY; Tae IH; Lee BM; Kim HS; Yoon S
    Anticancer Res; 2018 Sep; 38(9):5101-5108. PubMed ID: 30194155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenate specifically sensitizes drug-resistant cancer cells by increasing apoptosis via G2 phase cell cycle arrest without P-GP inhibition.
    Choi AR; Jee Jo M; Jung MJ; Sik Kim H; Yoon S
    Eur J Pharmacol; 2015 Oct; 764():63-69. PubMed ID: 26134503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SP600125 overcomes antimitotic drug-resistance in cancer cells by increasing apoptosis with independence of P-gp inhibition.
    Kim JH; Chae M; Choi AR; Sik Kim H; Yoon S
    Eur J Pharmacol; 2014 Jan; 723():141-7. PubMed ID: 24333214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine Kinase Inhibitors Imatinib and Erlotinib Increase Apoptosis of Antimitotic Drug-resistant KBV20C Cells Without Inhibiting P-gp.
    Kim JY; Kim HS; Yoon S
    Anticancer Res; 2019 Jul; 39(7):3785-3793. PubMed ID: 31262905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine Receptor Antagonists, Loratadine and Azelastine, Sensitize P-gp-overexpressing Antimitotic Drug-resistant KBV20C Cells Through Different Molecular Mechanisms.
    Kim JY; Kim KS; Kim IS; Yoon S
    Anticancer Res; 2019 Jul; 39(7):3767-3775. PubMed ID: 31262903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-treatment of Low Dose Pacritinib, a Phase III Jak2 Inhibitor, Greatly Increases Apoptosis of P-gp Over-expressing Cancer Cells With Multidrug Resistance.
    Oh Y; Lee JS; Lee JS; Park JH; Kim HS; Yoon S
    Anticancer Res; 2022 May; 42(5):2433-2442. PubMed ID: 35489775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thioridazine specifically sensitizes drug-resistant cancer cells through highly increase in apoptosis and P-gp inhibition.
    Choi AR; Kim JH; Yoon S
    Tumour Biol; 2014 Oct; 35(10):9831-8. PubMed ID: 24989930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salinomycin sensitizes antimitotic drugs-treated cancer cells by increasing apoptosis via the prevention of G2 arrest.
    Kim JH; Yoo HI; Kang HS; Ro J; Yoon S
    Biochem Biophys Res Commun; 2012 Feb; 418(1):98-103. PubMed ID: 22244892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.